STOCK TITAN
  1. Home
  2. IPATF

IPATF (IPATF) Stock Price, News & Analysis

IPATF OTC

Company Description

IPATF (OTC: IPATF) is classified in the biotechnology industry within the Health Technology sector.

This page collects what Stock Titan holds for IPATF, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart
$—
0.00%
0.00
Last updated:
-
Performance 1 year
$0.0
Market Cap
0.0
Shares outstanding

Latest News

View All
—

IPA Delivers Lead Candidate Antibodies from B Cell Select™ Platform for at Home SARS-CoV-2 Diagnostic Test

—

ImmunoPrecise Reports Revenue of $3.8 Million and Adjusted EBITDA of $932,000 for the First Quarter of Fiscal 2021

earnings
—

IPA CEO Dr. Jennifer Bath to Appear Live Today on Bloomberg Television

—

ImmunoPrecise and LiteVax SARS-CoV-2 Vaccine Begins Pre-Clinical Trials

clinical trial
—

IPA Europe Significantly Expands its Capabilities, Releasing its Second-Generation B Cell Select ™

—

ImmunoPrecise Announces New Multi-Specific SARS-CoV-2 Antibody Collaboration with Zymeworks

IPATF has 10 recent news articles. Key topics include earnings, clinical trial, conferences. View all IPATF news →

SEC Filings

View All

No SEC filings available for IPATF.

Financial Highlights

—
Revenue (latest FY)
—
Net Income (latest FY)
—
Diluted EPS (latest FY)
—
Operating Cash Flow
—
Net Profit Margin
—
Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

IPATF Company Profile & Sector Positioning

IPATF (IPATF) operates in the Biotechnology industry within the broader Health Technology sector and is listed on the OTC.